➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Colorcon
AstraZeneca
Dow
Harvard Business School

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

KHEDEZLA Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Khedezla patents expire, and when can generic versions of Khedezla launch?

Khedezla is a drug marketed by Osmotica Pharm Corp and is included in one NDA.

The generic ingredient in KHEDEZLA is desvenlafaxine. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the desvenlafaxine profile page.

US ANDA Litigation and Generic Entry Outlook for Khedezla

A generic version of KHEDEZLA was approved as desvenlafaxine by ALEMBIC PHARMS LTD on March 4th, 2013.

  Start Trial

US Patents and Regulatory Information for KHEDEZLA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Osmotica Pharm Corp KHEDEZLA desvenlafaxine TABLET, EXTENDED RELEASE;ORAL 204683-001 Jul 10, 2013 DISCN No No   Start Trial   Start Trial   Start Trial
Osmotica Pharm Corp KHEDEZLA desvenlafaxine TABLET, EXTENDED RELEASE;ORAL 204683-002 Jul 10, 2013 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Johnson and Johnson
McKesson
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.